Michael Singer
Board Member
Cartesian Therapeutics, Inc. (RNAC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Singer
Michael Singer is recorded as Board Member at Cartesian Therapeutics, Inc. (RNAC). Cartesian Therapeutics, Inc. reported in an 8-K filed November 13, 2023 that Michael Singer was appointed Director. Cartesian Therapeutics, Inc. reported in an 8-K filed November 13, 2023 that Michael Singer was appointed Class I director, effective November 13, 2023.
“The combined company's Board of Directors will be led by current Selecta Chairman Carrie S. Cox and will include, among others, current Selecta board member Timothy Springer, Ph.D., as well as Cartesian Co-Founders Murat Kalayoglu, M.D., Ph.D., and Michael Singer, M.D., Ph.D.”
“Pursuant to the Merger Agreement, on November 13, 2023, effective immediately after the Effective Time, Murat Kalayoglu, MD, Ph.D. and Michael Singer, MD, Ph.D., were appointed to the Board as Class II and Class I directors, respectively.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cartesian Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Carsten Brunn CEO, Board Member
- Carsten Brunn, Ph.D. Chairman
- Blaine Davis CFO, Chief Accounting Officer
- Kevin Tan CFO
- Metin Kurtoglu COO
- Metin Kurtoglu, M.D., Ph.D. COO
- June Seymour Chief Accounting Officer
- Adrian Bot Board Member
- Adrian Bot, M.D., Ph.D. Board Member
- Carrie S. Cox Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.